|
JAK1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.167590E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.237900E-03 |
| Normal-vs-Stage2 |
5.327200E-01 |
| Normal-vs-Stage3 |
1.597970E-01 |
| Normal-vs-Stage4 |
3.076200E-02 |
| Stage1-vs-Stage2 |
1.241620E-01 |
| Stage1-vs-Stage3 |
2.180600E-01 |
| Stage1-vs-Stage4 |
7.237000E-01 |
| Stage2-vs-Stage3 |
5.909600E-01 |
| Stage2-vs-Stage4 |
1.657400E-01 |
| Stage3-vs-Stage4 |
2.725600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.157400E-03 |
| Normal-vs-AfricanAmerican |
3.144000E-01 |
| Normal-vs-Asian |
1.194150E-01 |
| Caucasian-vs-AfricanAmerican |
5.060400E-01 |
| Caucasian-vs-Asian |
6.259400E-01 |
| AfricanAmerican-vs-Asian |
7.785800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.198500E-02 |
| Normal-vs-Female |
1.754230E-02 |
| Male-vs-Female |
6.696400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.541800E-03 |
| Normal-vs-Age(41-60Yrs) |
5.533800E-02 |
| Normal-vs-Age(61-80Yrs) |
2.082400E-01 |
| Normal-vs-Age(81-100Yrs) |
8.577800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.378000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.181800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.876800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.879200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.499000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.020400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.304200E-01 |
| Classical-VS-Follicular |
7.95230004069225E-09 |
| Classical-VS-Other |
5.884200E-02 |
| Classical-VS-Normal |
6.952400E-04 |
| Tall-VS-Follicular |
6.186800E-04 |
| Tall-VS-Other |
7.103700E-02 |
| Tall-VS-Normal |
1.135960E-02 |
| Follicular-VS-Other |
9.921600E-01 |
| Follicular-VS-Normal |
2.583200E-01 |
| Other-VS-Normal |
5.781400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.093400E-01 |
| Normal-vs-N1 |
3.798800E-01 |
| N0-vs-N1 |
8.500800E-01 |
|
|
